Novartis Wins Top Share Of HHS’ Initial Pandemic Flu Vaccine Contracts

Three large companies will get the lion's share of the federal government's first $1 billion in spending on development of vaccine for the emerging novel strain of influenza

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Pink Sheet